外体研究的进步:多面性作用在髓性白血病的进展和治疗
Jianlan Zheng1, Huafang Wang2, Lili Ge3
1Nephrology Center,Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, PR China.
Journal of biochemical and molecular toxicology
|May 22, 2025
概括
外体细胞在髓性白血病 (CML和AML) 的进展和药物耐药性方面发挥着关键作用. 对外体细胞生产和治疗策略的进一步研究可以改善白血病治疗.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 外体,小的细胞外囊泡,是细胞间通信的关键媒介.
- 它们影响细胞过程,包括生长,增殖,生存和亡.
- 在白血病中,外体细胞有助于疾病的进展和治疗耐药性.
研究的目的:
- 审查外体在髓性白血病 (CML和AML) 中的作用.
- 探索外体在向药物输送和针对白血病的个性化药物中的潜力.
主要方法:
- 关于与骨髓性白血病相关的外体细胞研究近期进展的文献综述.
- 对细胞间通信,疾病进展和治疗耐药性的外体功能分析.
主要成果:
- 外体细胞促进免疫逃避,增强瘤细胞的增殖,并促进白血病的血管生成.
- 外体细胞可以转移药物耐药性,并调节瘤微环境.
- 来自AML患者的外体可能含有抑制免疫细胞活性的细胞因子.
结论:
- 外体因其纳米粒子特性而具有显著的白血病治疗潜力.
- 在扩大临床应用的外体细胞体生产方面仍然存在挑战.
- 将外体生物与新型治疗策略的整合为改善白血病管理提供了希望.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


